Terms & Conditions

For the purpose of these T&Cs, the following terms shall have the meanings set out below:

• "Platform" means the Pomegranate Health India LLP website, mobile application, web-based tools, and all digital or online channels through which Services are provided, including designated WhatsApp Business accounts.
• "Services" means collectively: telehealth facilitation, GLP-1 based weight management programme, women's health consultations, men's health consultations, dermatology and skin services, wellness and longevity programmes, diagnostic test facilitation, medicine fulfilment facilitation, nutritional and behavioural coaching, and payment and financing options.
• "Unregistered User" or "Visitor" means any person who accesses the Platform without completing registration.
• "Registered User" or "Patient" means a person who has completed registration on the Platform and is eligible to access Services.
• "Primary User" means a person of 18 years of age or above, of sound mind and valid contractual capacity, who registers on the Platform and holds primary control over their account.
• "RMP" means a Registered Medical Practitioner duly registered under the National Medical Commission Act, 2020 or the applicable State Medical Council, who is empanelled as an independent consultant on the Platform.
• "HCP" means a Healthcare Provider, including RMPs and allied health professionals such as nutritionists, health coaches, and behavioural therapists empanelled or authorised by Pomegranate India.
• "Personal Data" has the meaning given to it in the Privacy Policy and includes identity, contact, health, wellness, technical, and financial information.
• "Agreement" means these T&Cs, the Privacy Policy, the Disclaimer, and any other policies applicable to specific Services, collectively.
• “DPDPA” means the Digital Personal Data Protection Act, 2023.
• “DPDP Rules” means the Digital Personal Data Protection Rules, 2025.
• “NMC” means the National Medical Commission, the apex body regulating medical education and practice in India.
• “Schedule H Medicine” means a prescription-only medicine listed under Schedule H of the Drugs and Cosmetics Rules, 1945.
• “TPG 2020” means the Telemedicine Practice Guidelines, 2020 issued by the National Medical Commission.

2.1 Pomegranate Health India LLP is a technology company. It owns and operates the Platform to facilitate access to independent healthcare professionals and wellness services. It is not a hospital, clinic, diagnostic centre, or pharmacy and does not itself practise medicine.

2.2 All clinical decisions, diagnoses, treatment recommendations, and prescriptions are made exclusively by independent RMPs. RMPs are independent consultants and are not employees or agents of Pomegranate India. Pomegranate India is not responsible for the clinical judgment, prescriptions, or professional conduct of empanelled RMPs.

2.3 Your use of the Platform does not create a doctor-patient, healthcare provider-patient, or any professional relationship between you and Pomegranate Health India LLP.

3.1 Unregistered Visitors

An Unregistered Visitor may access the Platform for the following permitted purposes only:

• Browsing general informational content on the Platform;
• Using publicly available self-assessment or eligibility tools; and
• Sharing the Platform link via social media or messaging applications.

Unregistered Visitors may not access any Services, teleconsultations, diagnostic facilities, prescription services, or restricted content. Any reliance on information viewed by an Unregistered Visitor is at their own risk. Pomegranate India disclaims all liability to Unregistered Visitors arising from the use of the Platform prior to registration.

3.2 Registered Patients

A Registered Patient, upon completing registration and accepting these T&Cs, is entitled to:

• Access all permitted Services subject to eligibility, clinical assessment, and applicable service-specific terms;
• Communicate with empanelled HCPs through the Platform’s designated communication channels;
• Access and manage their health records and consultation history through the Platform;
• Receive service-related communications via SMS, email, and WhatsApp Business linked to their registered contact details; and
• Exercise all data principal rights under the DPDPA 2023 as described in the Privacy Policy.

3.3 Empanelled RMPs

RMPs who have executed a separate RMP Empanelment Agreement with Pomegranate India and been granted a dedicated Platform account are permitted to:

• Access patient information shared with them through the Platform for the sole purpose of conducting consultations and providing clinical services;
• Generate, issue, and manage prescriptions through the Platform’s electronic prescription system in compliance with TPG 2020;
• Communicate with Registered Patients through the Platform’s designated channels; and
• Access clinical support tools, templates, and resources made available by Pomegranate India from time to time.

RMPs are governed by the RMP Empanelment Agreement, these T&Cs (to the extent applicable), the NMC Code of Ethics, and all applicable professional regulations. In the event of conflict between the RMP Empanelment Agreement and these T&Cs, the RMP Empanelment Agreement shall prevail.

4.1 To access Services, you must register on the Platform by providing accurate, complete, and current information. You represent and warrant that all information provided at registration and during use of the Platform is true, accurate, complete, and up to date.

4.2 You must be at least 18 years of age, of sound mind, and not debarred under any applicable law from entering into a binding contract, to register as a Primary User.

4.3 You are responsible for maintaining the confidentiality of your account credentials (username, password, and OTP). You must not share your account credentials with any other person. You are solely responsible for all activities conducted under your account, whether or not authorised by you.

4.4 You must immediately notify Pomegranate India at info@joinpomegranate.in of any actual or suspected unauthorised access to your account. Pomegranate India shall not be liable for any loss or damage arising from your failure to protect your account credentials.

4.5 Pomegranate India reserves the right to suspend, deactivate, or terminate your account at any time if it determines, in its sole discretion, that you have violated these T&Cs, provided false information, or engaged in any fraudulent, illegal, or harmful activity.

You agree to use the Platform and Services only for lawful purposes and in accordance with these T&Cs and all applicable Indian laws. You specifically agree that you will NOT:

• Provide false, inaccurate, misleading, or incomplete personal or health information on the Platform;
• Access or attempt to access any account, system, or data that you are not authorised to access;
• Use any automated tools, bots, crawlers, or scraping technologies to access, extract, or index Platform content;
• Interfere with, disrupt, or attempt to compromise the security, integrity, or performance of the Platform or its infrastructure;
• Use the Platform for any unlawful, immoral, fraudulent, or harmful purpose;
• Reproduce, distribute, modify, create derivative works of, or commercially exploit any Platform content without prior written consent;
• Impersonate any person or entity or misrepresent your identity or qualifications;
• Attempt to obtain prescription medicines without a valid prescription from an empanelled RMP;
• Share, sell, or transfer your Platform account or access credentials to any third party;
• Post, upload, or transmit any content that infringes third-party intellectual property rights, is defamatory, obscene, or otherwise unlawful; or
• Engage in any activity that violates the NMC Code of Ethics, the Telemedicine Practice Guidelines 2020, or any other applicable healthcare regulation (applies to RMPs specifically).

6.1 All intellectual property rights in the Platform and its content — including but not limited to the “Pomegranate Health” trademark, logo, wordmark, trade dress, software, databases, assessment tools, programme frameworks, and all text, graphics, and images — are owned by or licensed to Pomegranate Health India LLP or Pomegranate Health LLC (USA) as applicable. All rights are reserved.

6.2 The “Pomegranate Health” trademark and associated branding are used under licence from Pomegranate Health LLC, USA. Unauthorised use of the trademark constitutes infringement actionable under applicable Indian trademark law.

6.3 You are granted a limited, non-exclusive, non-transferable, revocable licence to access and use the Platform solely for personal, non-commercial purposes in accordance with these T&Cs. No other rights are granted. You must not remove, modify, or obscure any trademark, copyright notice, or other proprietary marking on the Platform.

6.4 Any feedback, suggestions, or improvements you provide to Pomegranate India regarding the Platform may be freely used by Pomegranate India without compensation or attribution to you.

7.1 Your use of the Platform is subject to our Privacy Policy, which is incorporated into these T&Cs by reference. By using the Platform, you agree to the collection, use, and processing of your personal data as described in the Privacy Policy.

7.2 By accepting these T&Cs, you provide Pomegranate India with consent to collect your Personal Data from relevant HCPs and to deliver information to you through secure platform channels, OTPs, and other authentication mechanisms.

7.3 You consent to receive service-related communications from Pomegranate India on your registered contact details via SMS, email, and WhatsApp Business, including appointment reminders, consultation updates, payment notifications, and security alerts.

8.1 To the fullest extent permitted by applicable Indian law, Pomegranate India’s aggregate liability to you for any claim arising out of or in connection with these T&Cs or the Services shall not exceed the total fees paid by you to Pomegranate India in the three (3) months preceding the event giving rise to the claim.

8.2 Pomegranate India shall not be liable for any indirect, incidental, consequential, special, or punitive damages, including loss of health, loss of data, loss of revenue, or medical complications arising from use of the Platform or reliance on Platform content.

8.3 Pomegranate India is not liable for the acts, omissions, clinical decisions, prescriptions, or professional conduct of independent RMPs, laboratories, pharmacies, or any other third-party service providers accessed through the Platform.

8.4 You agree to indemnify, defend, and hold harmless Pomegranate India, its partners, officers, employees, and agents from and against any claims, liabilities, damages, losses, and expenses (including legal fees) arising from: (a) your breach of these T&Cs; (b) your violation of applicable law; (c) your provision of false or inaccurate information; or (d) your misuse of the Platform or Services.

9.1 Pomegranate India will use commercially reasonable efforts to maintain Platform availability 24 hours a day, 7 days a week. However, availability is not guaranteed and may be interrupted by:

• Planned maintenance (communicated in advance where reasonably practicable);
• Unplanned outages, technical failures, or force majeure events; or
• Circumstances beyond Pomegranate India’s reasonable control including cyber-attacks, acts of government, floods, or ISP failures.

9.2 The Platform is intended for use within the Republic of India. Users accessing the Platform from outside India do so at their own risk. If you are travelling abroad during active treatment, you must inform your treating RMP and carry necessary prescriptions.

9.3 Pomegranate India reserves the right to add, modify, suspend, or discontinue any feature or Service at any time with reasonable notice to users.

10.1 In the event of any dispute, grievance, or claim arising out of or in connection with these T&Cs or the Services, you must first write to info@joinpomegranate.in. We will endeavour to resolve the matter within thirty (30) days.

10.2 If the dispute is not resolved through the internal grievance mechanism, it shall be referred to arbitration under the Arbitration and Conciliation Act, 1996 (as amended). The arbitration shall be conducted by a sole arbitrator mutually appointed by the parties, with the seat of arbitration at Srinagar, J&K, and proceedings conducted in English. The arbitral award shall be final and binding.

10.3 These T&Cs are governed by and shall be construed in accordance with the laws of the Republic of India. Subject to the arbitration clause above, the courts at Srinagar shall have exclusive jurisdiction.

10.4 Nothing in this clause shall prevent either party from seeking urgent injunctive or interim relief from a competent court.

11.1 Pomegranate India reserves the right to modify these T&Cs at any time. Material changes will be communicated to Registered Users via email or in-app notification at least fifteen (15) days before they take effect.

11.2 Your continued use of the Platform after the effective date of any amendment constitutes your acceptance of the revised T&Cs. If you do not accept the revised Terms, you must discontinue use of the Platform and notify us to deactivate your account.

Applicable to: All Registered Patients who access teleconsultation services through the Platform with empanelled RMPs.

12.1 Service Description

Pomegranate India facilitates on-demand and scheduled video, audio, or text-based teleconsultations between Registered Patients and empanelled RMPs in accordance with the Telemedicine Practice Guidelines, 2020 (“TPG 2020”).

12.2 Patient Obligations

• You must provide complete, accurate, and truthful health and medical information to your RMP. Withholding material information may affect the quality of care and the safety of any prescription issued.
• By booking or joining a teleconsultation you agree to receive care through the Platform under these Terms, the Disclaimer, and the Privacy Policy.
• You must be physically located in India at the time of availing any teleconsultation Service.
• You must not record any consultation without the prior consent of the RMP.

12.3 RMP Obligations

• Empanelled RMPs must conduct all consultations in compliance with TPG 2020, the NMC Code of Ethics, and applicable professional standards.
• RMPs must identify themselves to the patient at the commencement of every consultation, including their name and NMC/State Medical Council registration number.
• RMPs may, at their clinical discretion, decline to provide a teleconsultation and recommend an in-person consultation where they determine it is clinically necessary.
• RMPs must not prescribe medicines that are categorised as prohibited under TPG 2020 through the telemedicine channel.

12.4 Prescription Standards

Every prescription generated through the Platform must comply with the mandatory fields specified under TPG 2020, including: patient name and age, RMP name and registration number, drug name (generic), dosage, route of administration, frequency, duration, date of consultation, and digital signature of the RMP.

12.5 Consultation Records

All teleconsultation records, clinical notes, and prescriptions generated through the Platform will be retained for a minimum of three (3) years from the consultation date, in compliance with TPG 2020. You may access your consultation records through your Platform account.

12.6 Rescheduling & Cancellation

Teleconsultation appointments may be rescheduled or cancelled by either party subject to the cancellation and refund policy set out in Section 17. Pomegranate India may substitute an alternate RMP where the scheduled RMP is unavailable, and will notify you in advance where reasonably practicable.

13.1 Programme Description

The GLP-1 Based Weight Management Programme facilitates access to clinician-guided weight management using GLP-1 receptor agonist medications (including compounded semaglutide, compounded tirzepatide, and branded equivalents where available and clinically appropriate), combined with nutritional guidance, behavioural coaching, and progress monitoring.

13.2 Eligibility

Participation in the programme is subject to a mandatory medical eligibility assessment conducted by an empanelled RMP. The RMP will evaluate your BMI, medical history, comorbidities, current medications, and overall clinical suitability. Not all users will be eligible. The prescribing RMP’s eligibility decision is final and cannot be appealed to Pomegranate India.

13.3 Patient Obligations

• You must disclose your complete medical history, current medications, allergies, and any known contraindications to GLP-1 medications before or during your clinical assessment.
• You must attend all scheduled consultations and follow-up sessions with your assigned RMP.
• You must report any side effects, adverse reactions, or changes in health status to your RMP promptly. In the event of a serious adverse reaction, seek emergency medical care immediately.
• You understand that weight loss results vary between individuals and that no specific outcome is guaranteed.
• You must not self-administer any injectable medication without prior training and RMP clearance.

13.4 Programme Structure

13.5 Advertising & Promotional Restrictions

In compliance with the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954 and Schedule J of the Drugs and Cosmetics Rules, 1945, Pomegranate India does not advertise or promote specific prescription-only GLP-1 medications to the general public. All programme communications are positioned as facilitating access to qualified medical care.

Applicable to: Registered Patients availing women’s health consultations, PCOD management, hormonal therapy facilitation, menstrual health, and related services.

14.1 Scope of Services

Women’s health services on the Platform include facilitation of consultations for PCOD/PCOS management, hormonal imbalances, menstrual irregularities, thyroid conditions, weight management related to hormonal health, and general women’s wellness. All clinical assessments, diagnoses, and prescriptions are made exclusively by empanelled RMPs.

14.2 Key Terms

• All hormonal prescription medications (including oral contraceptive pills, metformin, hormone therapy preparations, and related medicines) are prescription-only Schedule H medicines and will only be dispensed against a valid RMP prescription.
• The Platform does not offer fertility treatment, IVF facilitation, or assisted reproductive technology services.
• Diagnostic investigations (including blood tests for hormonal profiles, thyroid function, and metabolic markers) may be recommended by the RMP as part of the clinical assessment.
• Women who are pregnant, planning pregnancy, or breastfeeding must disclose this to their RMP at the commencement of every consultation.

Applicable to: Registered Patients availing men’s health consultations including testosterone management, erectile dysfunction, hair loss, metabolic health, and related services.

All men’s health prescriptions, including testosterone and hormonal therapies and prescription medicines for erectile dysfunction and hair loss, are Schedule H medicines and are prescribed exclusively by empanelled RMPs following clinical assessment. You must disclose your complete medical history, cardiovascular history, and current medications to your RMP before initiating any treatment. Self-medication with hormonal preparations is dangerous and strictly prohibited on the Platform.

Applicable to: Registered Patients who access diagnostic test facilitation services through the Platform.

16.1 Service Description

Pomegranate India facilitates access to diagnostic tests through licensed third-party laboratories. This includes home sample collection, laboratory visits, and digital delivery of test reports to your Platform account.

16.2 Key Terms

• Diagnostic tests are conducted by independent, licensed third-party laboratories. Pomegranate India is not responsible for the accuracy, quality, turnaround time, or safety of laboratory services.
• Test results available on the Platform must be interpreted by your RMP in the context of your complete clinical picture. Test results do not constitute a diagnosis.
• Home sample collection is subject to the availability of the laboratory’s collection service in your area and the applicable laboratory’s terms and conditions.
• You must provide accurate address and contact details for sample collection. Failed collection attempts due to inaccurate information or your non-availability will not be eligible for a refund.
• Certain tests require fasting or specific preparation. You are responsible for following the preparation instructions communicated to you by the laboratory or through the Platform.

Applicable to: All Registered Patients availing any paid Service on the Platform.

17.1 Pricing & Fees

Pricing for all Services is displayed on the Platform at the time of selection. Pomegranate India reserves the right to modify pricing at any time. The price applicable to a Service will be the price displayed at the time you confirm your order or book your appointment.

17.2 Payment Methods

Payments may be made through the following modes:

• Major credit and debit cards (Visa, Mastercard, RuPay)
• UPI and net banking
• Buy Now Pay Later / EMI options through approved financing partners
• Any other payment method made available on the Platform from time to time

All payments are processed through RBI-authorised third-party payment gateways. Pomegranate India does not store your complete card or banking credentials.

17.3 GST & Taxes

All prices displayed on the Platform are inclusive of or exclusive of applicable Goods and Services Tax (GST) as indicated. GST invoices will be issued for all paid Services in compliance with the GST Act, 2017. You are responsible for any additional taxes applicable in your jurisdiction.

17.4 Cancellation Policy

Refunds, where applicable, will be processed to the original payment method within seven (7) to ten (10) working days of approval.

17.5 Failed & Disputed Payments

In the event of a failed payment, your Service access will not be activated until successful payment is confirmed. For payment disputes, please write to info@joinpomegranate.in within fourteen (14) days of the transaction date.

17.6 Subscription Services

Where Services are offered on a subscription basis, your subscription will auto-renew at the end of each billing cycle unless you cancel at least twenty-four (24) hours before the renewal date through your account settings or by writing to info@joinpomegranate.in.

Applicable to: Registered Patients who use connected devices (smart scales, continuous glucose monitors, wearables) or digital health tools integrated with the Platform.

18.1 Device Integration

The Platform may support integration with third-party connected health devices including smart scales, continuous glucose monitors, wearables, and similar tools. Device integrations are optional and occur only with your explicit authorisation. You may revoke device integration at any time through your Platform account settings.

18.2 Data from Devices

Health data generated by integrated devices (including weight, glucose readings, activity metrics, and biometric data) will be made available to your assigned RMP and care team for clinical monitoring and programme optimisation. Such data is governed by the Privacy Policy and constitutes sensitive personal data under the DPDPA 2023.

18.3 Device Responsibility

Pomegranate India is not responsible for the accuracy, quality, or malfunction of third-party devices. Device-related concerns must be addressed directly with the device manufacturer. Inaccurate device data must be reported to your RMP at the earliest opportunity.

The Platform may provide links to or integrations with third-party websites, applications, or service providers. Pomegranate India does not control, endorse, or accept responsibility for third-party content, privacy practices, or terms of use. Your use of third-party services is governed by their respective terms and is at your own risk.

20.1 Pomegranate India will adopt all reasonable measures to comply with applicable central and state government laws and regulations relating to healthcare, telemedicine, data protection, pharmacy, and consumer protection.

20.2 You may be required to complete KYC verification, health declarations, consent confirmations, or other compliance tasks as required by applicable law or Pomegranate India’s internal policies. Failure to complete required verifications may result in suspension or discontinuation of Services.

20.3 The Platform will not facilitate or enable any transaction or service that is prohibited under applicable Indian law, including the procurement of prescription medicines without a valid prescription.

Applicable to: All Registered Medical Practitioners empanelled on the Platform as independent consultants.

21.1 Independent Contractor Status

RMPs are engaged by Pomegranate India as independent consultants. Nothing in these T&Cs or the RMP Empanelment Agreement shall be construed to create an employer-employee, principal-agent, or partnership relationship between Pomegranate India and any RMP.

21.2 Registration & Credential Maintenance

RMPs must maintain valid, current registration with the NMC or the applicable State Medical Council at all times during their empanelment. Any suspension, cancellation, or adverse action on the RMP’s medical registration must be immediately disclosed to Pomegranate India and will result in immediate suspension of the RMP’s Platform access pending review.

21.3 Clinical Standards

• All consultations must be conducted in compliance with TPG 2020, the NMC Code of Ethics, and applicable professional guidelines.
• Prescriptions must comply with mandatory prescription standards under TPG 2020 and applicable drug laws.
• RMPs must not prescribe medicines classified as prohibited under TPG 2020 through the telemedicine channel.
• RMPs must maintain the confidentiality of patient information accessed through the Platform.
• RMPs must not use patient data accessed through the Platform for any purpose other than providing the Services for which such data was shared.

21.4 Fee Disbursement

Consultation fees are collected by Pomegranate India on behalf of the RMP and disbursed to the RMP’s registered bank account at the frequency specified in the RMP Empanelment Agreement, net of applicable Platform fees and TDS deductions as required under the Income Tax Act, 1961.

21.5 Indemnification by RMP

Each empanelled RMP agrees to indemnify and hold harmless Pomegranate India from and against any claims, liabilities, losses, and expenses (including legal fees) arising from: (a) the RMP’s clinical negligence or professional misconduct; (b) breach of the NMC Code of Ethics or TPG 2020; (c) the RMP’s violation of these T&Cs or the RMP Empanelment Agreement; or (d) any third-party claim arising from the RMP’s provision of clinical services through the Platform.

These Terms & Conditions are the current version and are effective from 24 October 2026.